These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 22152378

  • 21. Potential of (99m)Tc-MIBI SPECT imaging for evaluating non-alcoholic steatohepatitis induced by methionine-choline-deficient diet in mice.
    Rokugawa T, Uehara T, Higaki Y, Matsushima S, Obata A, Arano Y, Abe K.
    EJNMMI Res; 2014 Dec; 4(1):57. PubMed ID: 26116119
    [Abstract] [Full Text] [Related]

  • 22. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.
    Ji G, Wang Y, Deng Y, Li X, Jiang Z.
    Lipids Health Dis; 2015 Oct 24; 14():134. PubMed ID: 26498332
    [Abstract] [Full Text] [Related]

  • 23. Extracellular signal-regulated kinases 1/2 suppression aggravates transforming growth factor-beta1 hepatotoxicity: a potential mechanism for liver injury in methionine-choline deficient-diet-fed mice.
    Wang Z, Yao T, Song Z.
    Exp Biol Med (Maywood); 2010 Nov 24; 235(11):1347-55. PubMed ID: 20962016
    [Abstract] [Full Text] [Related]

  • 24. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
    Kassel KM, Guo GL, Tawfik O, Luyendyk JP.
    Lab Invest; 2010 Dec 24; 90(12):1794-804. PubMed ID: 20697377
    [Abstract] [Full Text] [Related]

  • 25. [Emodin worsens methionine-choline-deficient diet-induced non-alcoholic fatty liver disease in mice].
    Liu Q, Yu F, Yu N, Shi M, Wang F.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May 24; 31(5):620-4. PubMed ID: 25940288
    [Abstract] [Full Text] [Related]

  • 26. S100A4 Gene is Crucial for Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    Zhang YH, Ma Q, Ding P, Li J, Chen LL, Ao KJ, Tian YY.
    Yonsei Med J; 2018 Nov 24; 59(9):1064-1071. PubMed ID: 30328321
    [Abstract] [Full Text] [Related]

  • 27. Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression.
    Qin G, Wang GZ, Guo DD, Bai RX, Wang M, Du SY.
    J Dig Dis; 2018 May 24; 19(5):301-313. PubMed ID: 29696816
    [Abstract] [Full Text] [Related]

  • 28. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.
    Maina V, Sutti S, Locatelli I, Vidali M, Mombello C, Bozzola C, Albano E.
    Clin Sci (Lond); 2012 Jun 24; 122(11):545-53. PubMed ID: 22142284
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 6-gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism.
    Tzeng TF, Liou SS, Chang CJ, Liu IM.
    Nutrients; 2015 Feb 04; 7(2):999-1020. PubMed ID: 25658238
    [Abstract] [Full Text] [Related]

  • 31. [Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].
    Kong LB, Ren WG, Mi HM, Zhao SX, Zhang YG, Nan YM.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 04; 21(3):207-12. PubMed ID: 23967743
    [Abstract] [Full Text] [Related]

  • 32. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice.
    Yang YL, Kuo HC, Wang FS, Huang YH.
    Int J Mol Sci; 2019 Mar 26; 20(6):. PubMed ID: 30917489
    [Abstract] [Full Text] [Related]

  • 33. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I, Sutti S, Vacchiano M, Bozzola C, Albano E.
    Clin Sci (Lond); 2013 Feb 26; 124(4):279-87. PubMed ID: 22970906
    [Abstract] [Full Text] [Related]

  • 34. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar 26; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 35. Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis.
    Liu R, Pan X, Whitington PF.
    Liver Int; 2009 Mar 26; 29(3):337-43. PubMed ID: 18710424
    [Abstract] [Full Text] [Related]

  • 36. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.
    Galastri S, Zamara E, Milani S, Novo E, Provenzano A, Delogu W, Vizzutti F, Sutti S, Locatelli I, Navari N, Vivoli E, Caligiuri A, Pinzani M, Albano E, Parola M, Marra F.
    Clin Sci (Lond); 2012 Oct 26; 123(7):459-71. PubMed ID: 22545719
    [Abstract] [Full Text] [Related]

  • 37. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.
    Saleh DO, Ahmed RF, Amin MM.
    Appl Physiol Nutr Metab; 2017 Mar 26; 42(3):243-249. PubMed ID: 28177750
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.